NEW DELHI/MUMBAI, 23 FEB 2025: The government on Sunday said the combination of tapentadol and carisoprodol drugs is not approved in India, and prohibited production and export of such medicines, amid reports that an Indian company has been exporting the unlicensed combination. View Details

Related News

• Karnataka notifies NDPS Rules, Essential Narcotic Drugs to be regulated under Central Rules (22-03-2025)

---

• One hundred teams participated in 'Operation Garuda', uncovering nearly 40 different types of drugs being sold without prescriptions (22-03-2025)

---

• List of OTC drugs to be Submitted to Govt Soon: Panel Chief (21-03-2025)

---

• DCA seized four medicines for misleading 'Leucoderma', 'Tuberculosis' and 'Fever' treatment claims (21-03-2025)

---

• Skin specialists flag widespread quackery in Kerala (21-03-2025)

---

• SHRC orders criminal proceedings against fake doctor (21-03-2025)

---

• Gujarat HC stays GST action against Gujarat Medical Council, other boards (21-03-2025)

---

• CEPI and AstraZeneca to advance discovery into novel antibody (21-03-2025)

---

• FIR against 3 animal husbandry dept officials booked for sending damaged vaccine to Hospitals (21-03-2025)

---

• Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India (20-03-2025)

---